THE LARGEST COLLECTION OF JOBS ON EARTH
pharmaceutical
Supports PDF, DOC, DOCX, TXT, XLS, WPD, HTM, HTML files up to 5 MB
Bristol-Myers Squibb is a global Biopharma company committed to a single mission: to discover, develop, and deliver innovative medicines focused on helping millions of patients around the world in disease areas ..
Sign In or Sign Up in seconds to view this job on EmploymentCrossing.
... with a strong background in synthetic organic chemistry to join our ... of concept. Qualifications Ph.D. in synthetic organic chemistry with 10 years ... industrial experience or M.S. in..
At Bristol Myers Squibb, we are inspired by a single vision - transforming patients' lives through science.In oncology, hematology, immunology and cardiovascular disease - and one of the most diverse and ..
BioMarin is the world leader in delivering therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases. We target diseases that lack effective therapies and ..
ROLE SUMMARYPfizer's Oncology Research Unit (ORU) in La Jolla, California, is seeking a Scientist (non-PhD) focused on translating basic discoveries in the field of tumor biology into novel therapeutics.The Scientist will ..
RemeGen Biosciences is a biopharmaceutical company, focusing on the discovery and development of innovative biologics for the treatment of cancer and autoimmune diseases, based in South San Francisco, California, and Rockville, ..
HOW MIGHT YOU DEFY IMAGINATION?Youve earned your degree. How will you use that achievement to reach your goals? Do more with the knowledge youve worked hard to acquire and the passion ..
About IDEAYA Biosciences:IDEAYA Biosciences (NASDAQ: IDYA) is a public, clinical-stage synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using DNA ..
Who We Are For more than two decades, going our own way has led to countless breakthroughs, bettering the lives of those suffering from rare genetic disease. In 1997 we were ..